Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Follow-up of SMUP-IA-01 in Knee Osteoarthritis
NCT04339504Phase 1Recruiting
- Sponsor
- MEDIPOST
- Start
- Apr 2020
- Primary completion
- Dec 2025
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
Phase 1, open-label trial of SMUP-IA-01 in knee osteoarthritis (OA) (3 arms), sponsored by MEDIPOST. Primary endpoint: Change of total score in Western Ontario and McMaster University Osteoarthritis Index at 60 months. Started Apr 2020; status: recruiting.
02
Drugs
SMUP-IA-01
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04339504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04339504.